Latest News
Latest News
Feds May End Hospital System’s Noncompete Contract for Part-Time Docs
NLRB issued a complaint against Mount Sinai Health System for contracts that request confidentiality, bar docs from poaching.
Conference Coverage
Adjuvant Avelumab Benefits Seen in High Risk, Triple Negative BC
Researchers conduct first randomized phase 3 trial of patients with TNBC treated with adjuvant avelumab.
Conference Coverage
Clinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention?
Docs debate which dose of tamoxifen is best for reducing breast cancer risk at the ESMO Breast Cancer Congress.
From the Journals
Urticaria Linked to Higher Cancer Risk, Study Finds
Researchers compare the incident cancer risk between patients with urticaria and the general population using data from Danish healthcare...
Latest News
Postpartum Screening Critical for Urinary Symptoms and Related Mental Health
Study of underserved women finds that urinary symptoms are common and associated with different factors by subtype.
Feature
Time Warp: Fax Machines Still Common in Oncology Practice. Why?
Oncologists are among the many specialists across the country at the mercy of telecopiers.
Feature
Cancer Drug Shortages Continue in the US, Survey Finds
Not having enough of a significant spectrum of generic chemotherapies and supportive care medications is an ongoing issue, NCCN surveys suggest....
Latest News
FDA Proposes that Interchangeability Status for Biosimilars Doesn’t Need Switching Studies
The new draft guidance reflects updated scientific thinking on biosimilars, the agency said.
Latest News
Similar Outcomes With Labetalol, Nifedipine for Chronic Hypertension in Pregnancy
Maternal or neonatal outcomes were not significantly different between the two primary medication groups.
Commentary
How Well Do Clinicians Support Patients’ Sexual Health?
Sexuality needs to be addressed in addition to sexual health.
Conference Coverage
MUC-1 vaccine associated with notable overall survival rates in breast cancer
Patients with HER2-negative early breast cancer receive preoperative standard of care neoadjuvant treatment with or without tecemotide, in new...